Plain-English translation of NCT07400484 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying a protein called N-CAD (neural cadherin) and how the brain works differently in young children with autism compared to children with typical development. This study involves taking a small blood sample and using special brain imaging to look at brain activity while children are resting and during a developmental assessment. The goal is to understand whether this protein and brain function patterns might help explain autism.
Autism is a lifelong condition that affects how children develop and communicate, but scientists still don't fully understand the biological differences in the brains of children with autism. This research aims to identify whether measuring this specific protein and brain imaging patterns could help doctors better understand and possibly diagnose autism earlier.
You likely qualify if…
You likely don't qualify if…
If you join this study, your child will have a single visit where they receive a free physical exam, blood routine tests, and nutrient testing. A small 3ml blood sample will be taken and frozen for later analysis. Your child will also have their brain activity measured using a safe, non-invasive imaging technique called fNIRS (near-infrared brain imaging) while resting and during a developmental assessment called the Gesell assessment. You'll complete a questionnaire about your child's background and medical history. The entire process takes a few hours and involves no medications or invasive procedures.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
China